The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June ....
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 1.1 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Hector Asia Holdings II Pte. Ltd., the new promoter of HealthCare Global Enterprises (HCG), has disclosed the creation of encumbrance on its entire 7,16,77,991 equity shares (~51.41% of HCG's share capital) acquired on May 30, 2025 from the previous promoter Aceso Company Pte. Ltd. The encumbrance is a non-disposal undertaking (not a pledge) given to HSBC Singapore Branch as security for a USD 223 million (~INR 1,906 crore) offshore facility used to finance the acquisition of HCG shares. The encumbered shares are valued at ~INR 3,888 crore, giving a security cover of 2.04x. Encumbered shares represent 82.30% of total promoter shareholding (62.46% of HCG). Existing promoter-group member Dr. BS Ajaikumar separately holds ~10.40% with ~4.99% already encumbered.
This is a routine disclosure tied to the recent change of promoter at HCG — the new promoter has pledged its economic rights (non-disposal undertaking) to fund the acquisition. No new pledge was created on the shares, but the restriction means a large block of shares is locked in, which may limit near-term supply overhang but also signals leveraged acquisition financing.